Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment

Recruiting N/A Interventional Study
Porphyria, Acute Intermittent
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
50 (estimated)
Sponsor
Nordlandssykehuset HF · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The main aim of this clinical trial is to learn about the effect of carbohydrate-rich diet as a treatment for AIP (acute intermittent porphyria). Aim: Investigate the diet's impact on tissue and serum glucose, plasma insulin, cytokine levels, amino acids, and gut microbiota in AIP, and their correlation with PBG (Porphobilinogen). Aim: Assess the diet's effect on AIP symptoms and health status i…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Diagnosis of AIP Exclusion Criteria: * Not having diagnosis of AIP * Undergoing treatment as part of other clinical research on AIP * Pregnancy * Diabetes * Below 18 years of age
Contacts

Elin Storjord, MD PhD

97072484

elin.storjord@nordlandssykehuset.no

CONTACT

Hilde Thunhaug, Nurse

95057864

hilde.thunhaug@nordlandssykehuset.no

CONTACT